XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2012-06064
- Event Type
- Injury
- Date Received
- September 26, 2012
- Date of Event
- September 4, 2012
- Report Date
- September 4, 2012
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- NIQ
- PMA / PMN Number
- P110019
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY AND THE PRODUCT WAS NOT RETURNED. THE REPORTED PATIENT EFFECTS OF ANGINA AND THROMBOSIS, AS LISTED IN THE XIENCE PRIME INSTRUCTIONS FOR USE, ARE KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.
IT WAS REPORTED THAT APPROXIMATELY 1 MONTH POST XIENCE PRIME STENT IMPLANTATION IN THE CIRCUMFLEX, PLAVIX WAS DISCONTINUED BECAUSE OF A PLANNED UNRELATED SURGICAL PROCEDURE. ON (B)(6) 2012, THE PATIENT WAS HOSPITALIZED FOR THE URELATED PLANNED SURGERY. WHILE HOSPITALIZED, THE PATIENT EXPERIENCED ANGINA. ON (B)(6) 2012, DURING A DIAGNOSTIC ANGIOGRAPHY, STENT THROMBOSIS WAS FOUND IN THE PROXIMAL LEFT ANTERIOR DESCENDING ARTERY. THE THROMBUS WAS SUCTIONED AND ANGIOPLASTY WAS PERFORMED. THERE WAS NO ADVERSE PATIENT SEQUELA REPORTED. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM | DRUG ELUTING CORONARY STENT SYSTEM | NIQ | AV-TEMECULA-CT | 111104Q |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 84 YR | Hospitalization| R |